Skip to content

Pain, Acceptance, and Discomfort With Periodontally Accelerated Osteogenic Orthodontics (PAOO)

Evaluation of the Levels of Pain and Discomfort of 'Periodontally Accelerated Osteogenic Orthodontics' (PAOO) in the Leveling and Alignment of Crowded Lower Anterior Teeth: A Prospective Non-controlled Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04728464
Enrollment
16
Registered
2021-01-28
Start date
2018-08-29
Completion date
2020-11-01
Last updated
2021-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crowding of Anterior Mandibular Teeth

Keywords

Visual Analog Scale, Acceleration, moderate crowding

Brief summary

Patients will be examined in the Orthodontic Department of the University of Damascus Dental School. Patients who will be treated in conjunction with the PAOO procedure and subjects who will meet the inclusion criteria will be included then the initial diagnostic records (diagnostic gypsum models, internal and external oral photographs, as well as radiographic images) will be studied to ensure that the selection criteria will be accurately matched. This study aims to assess patients' acceptance of the PAOO procedure as well as the levels of pain and discomfort associated with this treatment.

Detailed description

Surgical procedure associated with PAOO The surgery will be performed under local anesthesia and then full-thickness flaps will be reflected labially only from the distal surface of the lower right canine to the distal surface of the lower left canine, after washing the exposed alveolar bone with saline, then a selective cortical cutting will be performed using a piezosurgery and then the Bone-D® xenograft (particle size of 0.2 mm-1.0 mm) from Medpark (Busan, Korea) will be placed, then the wound will be sutured. Then a schedule will be set up to review the patient after 1, 7, 14, and 28 days to fill out questionnaires related to pain, acceptance, discomfort, satisfaction, and follow-up to orthodontic treatment.

Interventions

PROCEDUREPeriodontally Accelerated Osteogenic Orthodontics (PAOO)

Fixed appliance will be placed for every patient, then surgical procedure will be applied after reflecting a full-thickness labial flap.

Sponsors

Damascus University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 28 Years
Healthy volunteers
No

Inclusion criteria

1. Class I malocclusion with moderate crowding (4-6 mm of a tooth-size-arch-length-discrepancy). 2. Good oral hygiene and periodontal health. 3. No severe skeletal discrepancy. 4. Normal proclination for the upper and lower incisors. 5. No congenitally missing or extracted teeth (except for the third molars).

Exclusion criteria

1. Bimaxillary dentoalveolar severe protrusion. 2. Previous orthodontic treatment. 3. Subject with psychological abnormalities. 4. Subject with systemic diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in perception of pain(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeksPatients will be asked about their pain perception (item 1 of the first questionnaire). How much pain did you have? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no pain - 100: the worst pain).
Change in perception of discomfort(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeksPatients will be asked about their discomfort (item 2 of the first questionnaire). How much discomfort did you have? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no discomfort - 100: the worst discomfort).
Change in the feeling of swelling(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeksPatients will be asked about how much they feel swollen (item 3 of the first questionnaire). How much swelling did you feel? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no swelling - 100: the worst swelling).
Change in the difficulty of mastication(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeksPatients will be asked about the difficulty of mastication (item 4 of the first questionnaire). How many difficulties in mastication did you have? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no difficulty of mastication - 100: the worst difficulty of mastication).
Change in difficulty swallowing(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeks]Patients will be asked about how difficult it is to swallow (item 5 of the first questionnaire). How many difficulties in swallowing did you feel? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no difficulty swallowing - 100: the worst difficulty swallowing).
Change in the limits of opening the mouth(1) one day following the beginning of the treatment, (2) after a week of the beginning of treatment, (3) after 2 weeks, (4) after 4 weeksPatients will be asked about the limits of the mouth opening limits (item 6 of the first questionnaire). How much mouth limitation did you feel? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: there is no limitation in opening the mouth - 100: the worst limits in opening the mouth).
Change in the level of satisfaction with accelerated treatment(1) after 4 weeks following the beginning of the treatmentPatients will be asked about satisfaction with accelerated treatment (item 1 of the second questionnaire). How much are you satisfied with your accelerated treatment? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered by the Visual Analog Scale (VAS). The patient will specify a point on the line that expresses his feels, the score is determined by measuring the distance from the beginning until the point identified by the patient. The analog scale is a 100 mm horizontal line with two focal points at its beginning and end (0: no satisfaction with accelerated treatment - 100: best satisfaction with accelerated treatment).
Recommendation for the procedure(1) after 4 weeks following the beginning of the treatmentPatients will be asked about a friend's recommendation for this procedure (item 2 of the second questionnaire). Would you recommend this procedure to a friend? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered. The scale is two-point (yes, no) and the patient will select one answer yes or no.
Taking any type of pain killers(1) after 4 weeks following the beginning of the treatmentPatients will be asked about taking any type of pain killers (item 3 of the second questionnaire). Did you take any type of pain killers during the treatment? A standardized questionnaire to assess pain, acceptance, and discomfort during the first month of treatment based on a set of questions that will be answered. The scale is two-point (Yes, No) and the patient will select one answer yes or no. If the patient's answer is (Yes), he is asked to specify the number of pain killers that he took during the treatment when did you take pain killers? How many tablets as a whole?

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026